Dry Eye Syndrome (DES)
10
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye
Impact of Filtration on Autologous Serum Eye Drops
Safety and Efficacy of Kelulut Honey Eyedrops in Dry Eye Disease
Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation
Dietary Supplementation on Tear Secretion and Inflammation in DES
Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye
Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%
Three Dimension Tomography of Eye Structures by White Light Imaging Device